CG
NMTR

Cutler Group’s 9 Meters Biopharma NMTR Stock Holding History

Cutler Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-220
Closed – – 5527
2022
Q3 		$0 Buy
220
+25
+13% +$124 ﹤0.01% 5754
2022
Q2 		$1K Hold
195
– – ﹤0.01% 4827
2022
Q1 		$2K Buy
195
+55
+39% +$751 ﹤0.01% 4836
2021
Q4 		$2K Sell
140
-60
-30% -$1.34K ﹤0.01% 4887
2021
Q3 		$5K Hold
200
– – ﹤0.01% 4523
2021
Q2 		$4K Sell
200
-285
-59% -$7K ﹤0.01% 4678
2021
Q1 		$11K Buy
485
+345
+246% +$10.6K ﹤0.01% 3762
2020
Q4 		$2K Hold
140
– – ﹤0.01% 4301
2020
Q3 		$2K Hold
140
– – ﹤0.01% 4181
2020
Q2 		$1K Hold
140
– – ﹤0.01% 4234
2020
Q1 		$1K Hold
140
– – ﹤0.01% 3870
2019
Q4 		$1K Hold
140
– – ﹤0.01% 3830
2019
Q3 		$2K Buy
140
+5
+4% +$101 ﹤0.01% 3596
2019
Q2 		$3K Buy
135
+20
+17% +$600 ﹤0.01% 3454
2019
Q1 		$4K Sell
115
-10
-8% -$432 ﹤0.01% 3107
2018
Q4 		$5K Buy
125
+30
+32% +$2.22K ﹤0.01% 2965
2018
Q3 		$12K Sell
95
-30
-24% -$5.15K ﹤0.01% 2565
2018
Q2 		$58K Buy
+125
New +$46K ﹤0.01% 1513

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Cutler Group's NMTR Position: Q4 2022 in Review

Cutler Group sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 220 shares.

Cutler Group first reported a position in NMTR in Q2 2018 and held it in 18 quarters. The position peaked at $58K in Q2 2018. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Cutler Group reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 220 9 Meters Biopharma shares in Q4 2022.
  • Cutler Group first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 18 quarters.
  • Cutler Group's 9 Meters Biopharma position peaked at $58K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.